The Adoptive Cell Transfer Congress 2019 aims to bring together the experts, industry professionals, and academic professors and students for discussions on the latest advances in CAR T-cell therapies, cell and gene therapies in immuno-oncology. The recent regulatory approval in the US and Europe raises strong hope for several CAR T-cell products to enter the clinic as a potential immuno-oncology therapy. Part of the Research & Technology Series, this conference offers experts working in the pharmaceutical industry and academia the opportunity to explore and discuss the developments, discoveries and therapeutic applications of T-cell receptors. Presentations will explore design and development strategies for the modification of patient and donor t cells, receptor engineering and target selection, and will review the advantages and challenges remaining in their use.
Along with the Adoptive Cell Transfer Congress, one can also access four co-located meetings:
- Liquid Biopsies Congress
- Flow Cytometry Congress
- TMB & Neoantigen Congress
- Novel Antibody Therapeutics Congress
Date: 10th-11th October 2019 | 9.00 am – 5.00 pm
Venue: London Heathrow Marriott Hotel, Bath Road Heathrow Airport, Hayes UB3 5AN
Website: http://www.global-engage.com/event/adoptive-cell-congress/
For any inquiries, please contact:
Jane Williams | jane@globalengage.co.uk | (0)1865 849841
